Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta(®) in healthy subjects: A randomized, double‐blind trial

por Wynne, Chris, Schwabe, Christian, Vincent, Emmanuelle, Schueler, Armin, Ryding, Janka, Ullmann, Martin, Ghori, Vishal, Kanceva, Radmila, Stahl, Michael
Publicado 2020

Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial

por Li, Xue-Ning, Xu, Hong-Rong, Cui, Ellen, Petersen, Kamilla Buchberg, Ryding, Janka, Ettrup, Anders, Østergaard, Jette Buch, Larsen, Frank
Publicado 2023